(0.62%) 5 077.75 points
(0.44%) 38 236 points
(0.76%) 17 571 points
(0.96%) $79.76
(1.92%) $1.969
(-0.14%) $2 307.80
(-1.04%) $26.47
(0.73%) $961.90
(0.16%) $0.934
(0.29%) $11.06
(0.10%) $0.799
(-1.40%) $91.96
@ $12.36
Išleistas: 14 vas. 2024 @ 16:30
Grąža: -4.77%
Ankstesnis signalas: vas. 12 - 22:00
Ankstesnis signalas:
Grąža: -1.98 %
Live Chart Being Loaded With Signals
Zynex, Inc., through its subsidiaries, designs, manufactures, and markets medical devices to treat chronic and acute pain; and activate and exercise muscles for rehabilitative purposes with electrical stimulation...
Stats | |
---|---|
Šios dienos apimtis | 269 443 |
Vidutinė apimtis | 192 104 |
Rinkos kapitalizacija | 378.64M |
EPS | $0 ( 2024-04-25 ) |
Kita pelno data | ( $0.0300 ) 2024-05-16 |
Last Dividend | $0.100 ( 2022-01-05 ) |
Next Dividend | $0 ( N/A ) |
P/E | 43.59 |
ATR14 | $0.0260 (0.22%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-04-30 | Lucsok Anna | Buy | 1 025 | Common Stock (Restricted Stock Award) |
2024-04-27 | Lucsok Anna | Buy | 5 000 | Common Stock (Restricted Stock Award) |
2024-04-29 | Lucsok Anna | Sell | 2 395 | Common Stock |
2024-03-25 | Moorhead Daniel J | Sell | 6 084 | Common Stock |
2024-03-25 | Lucsok Anna | Sell | 7 672 | Common Stock |
INSIDER POWER |
---|
-36.67 |
Last 100 transactions |
Buy: 371 745 | Sell: 901 167 |
Tūris Koreliacija
Zynex Inc Koreliacija
10 Labiausiai teigiamai susiję koreliacijos | |
---|---|
MMAC | 0.896 |
BOCH | 0.863 |
BMRN | 0.848 |
CTRN | 0.841 |
STRO | 0.838 |
XEL | 0.832 |
CAAS | 0.826 |
ISRG | 0.821 |
AMRB | 0.814 |
GLSI | 0.812 |
10 Labiausiai neigiamai susiję koreliacijos | |
---|---|
APOP | -0.971 |
RMRM | -0.939 |
MAGS | -0.936 |
TDAC | -0.897 |
CMLF | -0.868 |
SVOK | -0.836 |
EMBCV | -0.824 |
TLGT | -0.823 |
SPRT | -0.82 |
TALS | -0.82 |
Ar žinojote?
Koreliacija yra statistinis rodiklis, aprašantis ryšį tarp dviejų kintamųjų. Jis svyruoja nuo -1 iki 1, kur -1 reiškia tobulo neigiamo ryšio koreliaciją (padidėjus vienam kintamajam, sumažėja kitas), 1 reiškia tobulo teigiamo ryšio koreliaciją (padidėjus vienam kintamajam, padidėja ir kitas), o 0 reiškia jokios koreliacijos (tarp kintamųjų nėra jokio ryšio).
Koreliacija gali būti naudojama analizuojant bet kurių dviejų kintamųjų ryšį, ne tik akcijų. Jis dažnai naudojamas finansų, ekonomikos, psichologijos ir kitose srityse.
Zynex Inc Koreliacija - Valiuta/Žaliavos
Zynex Inc Finansinės ataskaitos
Annual | 2023 |
Pajamos: | $184.32M |
Bruto pelnas: | $145.96M (79.19 %) |
EPS: | $0.270 |
FY | 2023 |
Pajamos: | $184.32M |
Bruto pelnas: | $145.96M (79.19 %) |
EPS: | $0.270 |
FY | 2022 |
Pajamos: | $158.17M |
Bruto pelnas: | $126.16M (79.77 %) |
EPS: | $0.440 |
FY | 2021 |
Pajamos: | $130.30M |
Bruto pelnas: | $102.98M (79.03 %) |
EPS: | $0.450 |
Financial Reports:
No articles found.
Zynex Inc Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
First Dividend | $0.136 | 2014-06-17 |
Last Dividend | $0.100 | 2022-01-05 |
Next Dividend | $0 | N/A |
Payout Date | 2022-01-21 | |
Next Payout Date | N/A | |
# dividends | 3 | -- |
Total Paid Out | $0.300 | -- |
Avg. Dividend % Per Year | 0.21% | -- |
Score | 2.52 | -- |
Div. Sustainability Score | 9.15 | |
Div.Growth Potential Score | 5.53 | |
Div. Directional Score | 7.34 | -- |
Year | Amount | Yield |
---|---|---|
2014 | $0.136 | 42.00% |
2015 | $0 | 0.00% |
2016 | $0 | 0.00% |
2017 | $0 | 0.00% |
2018 | $0.0636 | 2.14% |
2019 | $0 | 0.00% |
2020 | $0 | 0.00% |
2021 | $0 | 0.00% |
2022 | $0.100 | 1.07% |
2023 | $0 | 0.00% |
2024 | $0 | 0.00% |
The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. However, its Dividend Growth Potential Score (DGPS) is only moderate, indicating limited growth potential. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
OXSQ | Dividend Diamond | 2023-12-14 | Monthly | 21 | 9.10% | 8.50 |
PSEC | Dividend Royal | 2023-12-26 | Monthly | 21 | 7.04% | 8.50 |
SLVO | Dividend Royal | 2023-11-20 | Monthly | 12 | 10.77% | 8.50 |
QYLD | Dividend Royal | 2023-11-20 | Monthly | 11 | 7.50% | 8.50 |
GAIN | Dividend Royal | 2023-12-04 | Monthly | 20 | 8.19% | 8.50 |
GLDI | Dividend Royal | 2023-11-20 | Monthly | 12 | 7.15% | 8.50 |
OXLC | Dividend Royal | 2023-12-14 | Monthly | 14 | 10.00% | 8.50 |
HRZN | Dividend King | 2023-12-18 | Monthly | 15 | 6.60% | 8.45 |
USOI | Dividend Royal | 2023-11-20 | Monthly | 8 | 16.70% | 8.28 |
PFLT | Dividend King | 2023-11-15 | Monthly | 14 | 6.50% | 8.27 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.0433 | 1.500 | 9.13 | 10.00 | [0 - 0.5] |
returnOnAssetsTTM | 0.0647 | 1.200 | 7.84 | 9.41 | [0 - 0.3] |
returnOnEquityTTM | 0.163 | 1.500 | 9.30 | 10.00 | [0.1 - 1] |
payoutRatioTTM | 0.000367 | -1.000 | 10.00 | -10.00 | [0 - 1] |
currentRatioTTM | 3.58 | 0.800 | 10.00 | 8.00 | [1 - 3] |
quickRatioTTM | 2.68 | 0.800 | 10.00 | 8.00 | [0.8 - 2.5] |
cashRatioTTM | 1.511 | 1.500 | 2.72 | 4.08 | [0.2 - 2] |
debtRatioTTM | 0.598 | -1.500 | 0.0397 | -0.0596 | [0 - 0.6] |
interestCoverageTTM | 22.13 | 1.000 | 2.91 | 2.91 | [3 - 30] |
operatingCashFlowPerShareTTM | 0.555 | 2.00 | 9.81 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 0.519 | 2.00 | 9.74 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 2.28 | -1.500 | 0.884 | -1.326 | [0 - 2.5] |
grossProfitMarginTTM | 0.797 | 1.000 | 0.0581 | 0.0581 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.0584 | 1.000 | -0.832 | -0.832 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 0.238 | 1.000 | 9.79 | 9.79 | [0.2 - 2] |
assetTurnoverTTM | 1.495 | 0.800 | 3.37 | 2.69 | [0.5 - 2] |
Total Score | 9.15 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 46.58 | 1.000 | 5.40 | 0 | [1 - 100] |
returnOnEquityTTM | 0.163 | 2.50 | 9.55 | 10.00 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 0.519 | 2.00 | 9.83 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 0 | 1.500 | 0 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 0.555 | 2.00 | 9.81 | 10.00 | [0 - 30] |
payoutRatioTTM | 0.000367 | 1.500 | 10.00 | -10.00 | [0 - 1] |
pegRatioTTM | 0.879 | 1.500 | 7.47 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.0952 | 1.000 | -0.120 | 0 | [0.1 - 0.5] |
Total Score | 5.53 |
Zynex Inc
Zynex, Inc., through its subsidiaries, designs, manufactures, and markets medical devices to treat chronic and acute pain; and activate and exercise muscles for rehabilitative purposes with electrical stimulation. The company offers NexWave, a dual channel, multi-modality interferential current, transcutaneous electrical nerve stimulation, and neuromuscular electrical stimulation (NMES) device that is marketed to physicians and therapists by field sales representatives; NeuroMove, an electromyography triggered electrical stimulation device; InWave, an electrical stimulation product for the treatment of female urinary incontinence; and E-Wave, an NMES device. It also supplies private labeled products, including electrodes for the delivery of electrical current to the body, and batteries for use in electrotherapy products. In addition, the company distributes Comfortrac/Saunders for cervical traction, JetStream for hot/cold therapy, LSO Back Braces for lumbar support, and knee braces for knee support. Further, it offers Zynex Fluid Monitoring System (CM-1500), a fluid volume monitor, which is a non-invasive medical device for monitoring relative fluid volume changes used in operating and recovery rooms to detect fluid loss during surgery and internal bleeding during recovery; Zynex Wireless Fluid Monitoring System (CM-1600), a noninvasive monitoring device designed to measure relative changes in fluid volume in adult patients; NiCO CO-Oximeter, a laser-based noninvasive co-oximeter; and HemeOx tHb Oximeter, a laser-based total hemoglobin pulse oximeter. The company provides its products for use in pain management and control; stroke and spinal cord injury rehabilitation; hemodynamic monitoring; and pulse oximetry monitoring. It sells its products through direct sales force primarily in the United States. Zynex, Inc. was founded in 1996 and is headquartered in Englewood, Colorado.
Apie Signalai gyvai
Šiame puslapyje pateikti tiesioginiai signalai padeda nustatyti, kada PIRKTI ar PARDUOTI NA. Signalai vėluoja 1 minutę; kaip ir su visais rinkos signalais, taip ir su šiais, visuomet yra klaidų tikimybė.
Tiesioginiai prekybos signalai nėra apibrėžti, todėl getagraph.com neprisiima atsakomybės už jokius veiksmus, kurių buvo imtasi žinant šiuos signalus, kaip aprašyta Naudojimo sąlygose. Signalai yra pagrįsti įvairiais techninės analizės rodikliais.